Fulgent Genetics to Acquire Bako Diagnostics Assets and StrataDx for $55.5 Million [Los Angeles Times (CA)]
Fulgent Genetics, Inc. (FLGT)
Last fulgent genetics, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fulgentgenetics.com
Company Research
Source: Los Angeles Times
Alpharetta, GA, and to acquire StrataDx , a dermatopathology laboratory headquartered in Lexington, MA. The total combined purchase price is approximately $55.5 million and will be paid using cash on hand, with the acquisitions expected to close in the first half of 2026. “With the addition of Bako and StrataDx, we will be able to broaden our capabilities in the pathology testing market and further leverage our investments in AI to improve efficiency and quality, which will drive continued momentum in our laboratory services business,” said Ming Hsieh , chairman and chief executive of Fulgent, in a statement. “Our business has been growing organically at double-digit rates for several quarters, and, following closing, we will be able to layer on Bako's services to our testing menu to further strengthen our laboratory services business.” Fulgent Genetics is building upon its laboratory services platform through multiple vectors, including expanding its test menu through R&D, part
Show less
Read more
Impact Snapshot
Event Time:
FLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLGT alerts
High impacting Fulgent Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
FLGT
News
- Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- Fulgent Genetics to buy Bako Diagnostics assets and StrataDx [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDxBusiness Wire
- Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating [Seeking Alpha]Seeking Alpha
FLGT
Earnings
- 11/7/25 - Beat
FLGT
Analyst Actions
- 11/14/25 - Raymond James Financial, Inc.
FLGT
Sec Filings
- 12/22/25 - Form 8-K
- 12/3/25 - Form 4
- 12/3/25 - Form 4
- FLGT's page on the SEC website